Aspen Aerogels (ASPN) Expected to Release Quarterly Earnings on Thursday

Aspen Aerogels (NYSE:ASPN) is anticipated to release its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of ($0.2275) per share and revenue of $42.4220 million for the quarter. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Parties may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:30 AM ET.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Thursday, May 7th. The construction company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The business had revenue of $37.88 million during the quarter, compared to the consensus estimate of $36.58 million. During the same period in the previous year, the business earned ($0.06) earnings per share. The firm’s revenue for the quarter was down 51.8% compared to the same quarter last year. On average, analysts expect Aspen Aerogels to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Aspen Aerogels Stock Up 6.9%

Shares of NYSE:ASPN opened at $5.06 on Wednesday. The stock’s 50-day moving average is $5.53 and its 200 day moving average is $4.38. The company has a market cap of $419.11 million, a PE ratio of -3.72 and a beta of 2.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.89 and a quick ratio of 2.54. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.78.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Invesco Ltd. boosted its position in shares of Aspen Aerogels by 237.9% during the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after purchasing an additional 2,907,558 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Aspen Aerogels by 105.4% in the second quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock worth $7,379,000 after purchasing an additional 639,753 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Aspen Aerogels by 89.7% in the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after purchasing an additional 602,586 shares in the last quarter. State Street Corp raised its holdings in Aspen Aerogels by 28.6% in the fourth quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock worth $7,079,000 after purchasing an additional 556,833 shares in the last quarter. Finally, Millennium Management LLC lifted its position in Aspen Aerogels by 59.6% during the third quarter. Millennium Management LLC now owns 1,447,517 shares of the construction company’s stock valued at $10,075,000 after buying an additional 540,772 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ASPN. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Roth Capital restated a “buy” rating and set a $5.75 target price on shares of Aspen Aerogels in a report on Friday, May 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. Finally, Barclays lifted their price target on shares of Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a report on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $5.19.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.